Not applicableStudy completedNCT05079113
What this trial is testing
Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting
Who this might be right for
Stage III MelanomaStage IV Cutaneous Melanoma
Case Comprehensive Cancer Center 73